Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Etoricoxib 90 mg + Diacerein 50 mg Capsule Compared to Meloxicam 15 mg + Diacerein 50 mg in Patients With Knee and/or Hip Osteoarthritis: A Phase III, Controlled, Randomized, Double-blind, Multicenter Clinical Trial.

NCT07549386 is registered in ClinicalTrials.gov with Laboratorios Liomont as lead sponsor.

NCT NCT07549386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07549386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Etoricoxib 90 mg + Diacerein 50 mg Capsule Compared to Meloxicam 15 mg + Diacerein 50 mg in Patients With Knee and/or Hip Osteoarthritis: A Phase III, Controlled, Randomized, Double-blind, Multicenter Clinical Trial.
Lead sponsor
Laboratorios Liomont
Phase
Phase 3
Overall status
Completed
Start date
May 24, 2024
Completion date
October 15, 2025
Enrollment
123 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, pain management